The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) first adjuvanted vaccine for the prevention of H5N1 influenza, also known as avian or bird flu. The pandemic Influenza A (H5N1) Virus Monovalent Vaccine, ...
Tags: Bird Flu Vaccine, GlaxoSmithKline
The U.S. Food and Drug Administration approved the first adjuvanted pandemic influenza vaccine, Q-pan, to protect against H5N1 influenza, or avian flu. The vaccine, manufactured by GlaxoSmithKline, was developed in partnership with the ...
GlaxoSmithKline (GSK) and Amicus Therapeutics have announced that Amicus has received global rights for the global drug development, regulatory and commercial activities of migalastat HCl as a monotherapy and in combination with enzyme ...
Tags: GlaxoSmithKline, Fabry Agreement
Quackity quack, the quacks are back, and this time they're targeting fish oil supplements, claiming that taking fish oils raises your risk of prostate cancer. Hogwash. This is just another case of pure fearmongering quackery by the ...
GlaxoSmithKline (GSK) and Theravance have received marketing authorization from the European Commission (EC) for their jointly-developed asthma and chronic obstructive pulmonary disease (COPD) drug 'Relvar Ellipta'. Relvar, which is a ...
Tags: GSK, Relvar Ellipta
UK-based GlaxoSmithKline (GSK) and US-based Theravance have announced the availability of BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease (COPD), in the US pharmacies. BREO ELLIPTA is a ...
The Cyber Security Challenge UK (CSC UK), a series of national events designed to encourage talented professionals to join the UK IT security industry, is a government- and industry-backed initiative that has enabled 40 participants to ...
Tags: Computer Products, software
British drug maker GlaxoSmithKline (GSK) has received positive opinion from the European Medicines Agency (EMA's) Committee for Medicinal Products for Human Use (CHMP) for additional indication for Synflorix, a pediatric pneumococcal ...
Tags: drug, Pneumonia Indication
UK-based pharmaceutical company GlaxoSmithKline (GSK) has reached an agreement with Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), the Brazilian funding agency for scientific research, to establish a new center of excellence ...
Tags: Sustainable Chemistry, Medicine
GlaxoSmithKline (GSK) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA dry powder ...
Tags: Asthma Treatment, Medicine
GlaxoSmithKline (GSK) and Danish biotechnology firm Genmab have filed a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) for the use of its leukaemia drug Arzerra (ofatumumab) in combination ...
Tags: GlaxoSmithKline, CLL Patients
Danish biotechnology firm Genmab has unveiled positive results from a Phase II study of its sclerosis drug candidate ofatumumab in relapsing-remitting multiple sclerosis (RRMS). In a randomized study of 232 patients with RRMS, treatment ...
Tags: Genmab, Sclerosis Drug
In 2012, although the growth rate of global demand for industrial robots has slowed down, the sales volume of robots worldwide set the record the second highest just after that in 2011 and arrived at 159,000 units. In particular, ...
Tags: Robot Industry
The US Food and Drug Administration (FDA) has approved breakthrough therapy designation for Danish biotechnology company Genmab and British pharmaceutical company GlaxoSmithKline’s (GSK) Arzerra (ofatumumab) in combination with ...
Tags: therapy designation, Medicine
The Pulmonary-Allergy Drugs Advisory Committee (PADAC) of the US Food and Drug Administration (FDA) has recommended the approval of GlaxoSmithKline (GSK) and Theravance's umeclidinium/vilanterol as a treatment for chronic obstructive ...
Tags: Health, Medicine, Investigational Copd Drug